Express Pharma - Page 22 of 2164 - Express Pharma

The invisible threat: Why packaging inks are the next major recall risk for pharma

Advanced excipients: India’s gate to high-value drug formulation

Rx Propellant appoints Ashish Singh as CEO and MD

Zydus receives tentative approval from US FDA for Empagliflozin and Linagliptin tablets

Crane NXT to acquire Antares Vision; overall transaction expected to close in first half of 2026

Avantor collaborates with Mission-Critical Solutions at CPHI & PMEC India 2025

Glenmark Pharmaceuticals receives EIR from US FDA for its Monroe facility

The development of medico-legal governance in pharma companies

Eisai completes rolling submission to US FDA for LEQEMBI IQLIK supplemental biologics license application

Panel Discussion: Moving up the value chain without losing volume advantage

Dr Huzaifa Shabbir Choonia, Director and Head, Drug Substance-MSAT, OneSource

Mr Markus Obkircher, Director, Head of Customer Solutions R&D, Chemistry, Merck KGaA

Dr Rakesh Bhasin, Head R&D (Formulations), Biocon